We chose four cell types – mouse embryonic fibroblasts, (MEFs), L1210 mouse lymphocytic leukemia cells, FL5.12 mouse prolymphocytic cells, and CD8 T cells from an OT-1 transgenic mouse – and manipulated the proliferative state of each. This evidence concerns the gene CD8A and lymphoid leukemia.